An Assessment of Effectiveness of Nayanasukha Varti Anjana with Antioxidant Therapy in Kaphaja Kacha (Senile Immature Cortical Cataract)- A Randomized Controlled Clinical Trial.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To study the effect of Nayanasukha Varti Anjana on symptoms of Kaphaja Kacha (Senile Immature Cortical Cataract) such as Tanuchailavrottopamam (Cloudy Vision), Nishprabh Induarkapradip (Lustreless Vision), Glare, Polyopia/Diplopia.
研究概览
简要总结
This Randomized Controlled Clinical Trial is designed to evaluate the effectiveness of Nayanasukha Varti Anjana along with Antioxidant Therapy in management of Kaphaja Kacha(Senile Immature Cortical Cataract). A total of 60 patients between age group of 45-65years of age will be randomly selected and will be divided in two groups: The Control Group will receive Antioxidant Therapy only. The Trail group will receive Nayanasukha Varti Anjana along with Antioxidant Therapy for total 60 days. Assessment will be done on 0th,15th,30th,45th and 60th day and it will be based on subjective parameters such as Cloudy Vision, Lusterless Vision, Glare, Diplopia and objective parameters such as Visual Acuity, Contrast Sensitivity Test, Slit Lamp Examination for Cataract Gradation such as LOCS III Criteria And Gradation based on Quadrant Occupied(COR)Criteria. Data will be statistically analyzed to determine the efficacy of Nayanasukha Varti Anjana in improving vision and reducing and delaying further growth of senile immature cortical cataract along with Antioxidant Therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 45.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having symptoms of Senile Immature Cortical Cataract (Kaphaja Kacha) such as Cloudy vision (Tanuchailavrottopamam),Lustreless Vision (Nishprabh Induarkapradip), Gradual loss of vision (Drushti Hiyate Kramat), Glare.
- •Uniocular Polyopia/Diplopia.
- •Visual acuity between 6/9-6/36 by Snellen’s chart.
排除标准
- •Patients with Mature cataract and Hyper mature cataract. Visual acuity.
- •less than 6/36 by Snellen’s chart. Patients with congenital and developmental, traumatic, complicated or metabolic cataract. Patients having any other Posterior Segment Disease such as ARMD, NPDR. Patients who are a K/C/O Uncontrolled DM/HTN/TB/IHD. Patients having any other Serious Systemic Disease, Glaucoma. Patients having symptoms of Timir, Vataj Kacha, Pittaj Kacha, All types of Linganash.
结局指标
主要结局
To study the effect of Nayanasukha Varti Anjana on symptoms of Kaphaja Kacha (Senile Immature Cortical Cataract) such as Tanuchailavrottopamam (Cloudy Vision), Nishprabh Induarkapradip (Lustreless Vision), Glare, Polyopia/Diplopia.
时间窗: Follow Up on 0th 15th 30th 45th 60th & 90th day with assessment
次要结局
- 1.To study the effect seen in Visual Acuity.(2.To evaluate changes in Cataract Gradation, Graded as per Lens Opacification Criteria System (LOCS) III and Simplified Cataract Grading System based on Quadrant Occupied (COR).)
研究者
Dr Neha Anant Bhatavadekar
Dr. G. D.Pol Foundation, YMT Ayurvedic Medical College.